Zhuo Yu

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Venues

Journal of hepatocellular carcinoma

Journal of clinical and translational hepatology

Science advances

Journal of nanobiotechnology

Shanghai University of Traditional Chinese Medicine

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Shanghai University of Traditional Chinese Medicine Jul 01 2013

China

Physician Scientist :: Liver Disease Department, Shuguang Hospital

Publications

Xuemei Zhang, Kun Liu, Xiaona Lu, Wenlan Zheng, Jia Shi, Shihan Yu, Hai Feng, Zhuo Yu
Late-onset Cholestasis with Paucity of Portal Area Secondary to HNF1β Deficiency in Adulthood: A Case Report. Journal of clinical and translational hepatology 12 (3) (2024)
Xuemei Zhang, Kun Liu, Xiaona Lu, Wenlan Zheng, Jia Shi, Shihan Yu, Hai Feng, Zhuo Yu
Late-onset Cholestasis with Paucity of Portal Area Secondary to HNF1β Deficiency in Adulthood: A Case Report. Journal of clinical and translational hepatology 12 (3) (2024)
Shulan Han, Xueying Bao, Yifang Zou, Lingzhi Wang, Yutong Li, Leilei Yang, Anqi Liao, Xuemei Zhang, Xin Jiang, Di Liang, Yun Dai, Qing-Chuan Zheng, Zhuo Yu, Jianfeng Guo
d-lactate modulates M2 tumor-associated macrophages and remodels immunosuppressive tumor microenvironment for hepatocellular carcinoma. Science advances 9 (29) (2023)
Hai Feng, Yunhui Zhuo, Xuemei Zhang, Yuyao Li, Yue Li, Xiangjuan Duan, Jia Shi, Chengbin Xu, Yueqiu Gao, Zhuo Yu
Tumor Microenvironment in Hepatocellular Carcinoma: Key Players for Immunotherapy. Journal of hepatocellular carcinoma 9 (2022)
Yuyao Li, Yue Li, Jinghao Zhang, Longshan Ji, Man Li, Xuehua Sun, Hai Feng, Zhuo Yu, Yueqiu Gao
Current Perspective of Traditional Chinese Medicines and Active Ingredients in the Therapy of Hepatocellular Carcinoma. Journal of hepatocellular carcinoma 9 (2022)
Zhuo Yu, Jianfeng Guo, Yun Liu, Menglin Wang, Zhengsheng Liu, Yueqiu Gao, Leaf Huang
Nano delivery of simvastatin targets liver sinusoidal endothelial cells to remodel tumor microenvironment for hepatocellular carcinoma. Journal of nanobiotechnology 20 (1) (2022)
Mengying Hu, Ying Wang, Zhengsheng Liu, Zhuo Yu, Kaiyun Guan, Mengrui Liu, Menglin Wang, Jun Tan, Leaf Huang
Hepatic macrophages act as a central hub for relaxin-mediated alleviation of liver fibrosis. Nature nanotechnology 16 (4) (2021)
Zhuo Yu, Hai Feng, Yunhui Zhuo, Man Li, Xiaojun Zhu, Lingying Huang, Xin Zhang, Zhenhua Zhou, Chao Zheng, Yun Jiang, Fan Le, Dae-Yeul Yu, Alfred Szelok Cheng, Xuehua Sun, Yueqiu Gao
Bufalin inhibits hepatitis B virus-associated hepatocellular carcinoma development through androgen receptor dephosphorylation and cell cycle-related kinase degradation. Cellular oncology (Dordrecht) 43 (6) (2020)

Zhuo Yu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Zhuo Yu